Minute amounts of helicase-deficient truncated RECQL4 are sufficient for DNA replication.
Saved in:
| Title: | Minute amounts of helicase-deficient truncated RECQL4 are sufficient for DNA replication. |
|---|---|
| Authors: | Buco PAV; Centre for Innate Immunity and Infection Diseases, Hudson Institute of Medical Research, Clayton, Victoria, 3168, Australia.; St Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, 3065, Australia., Castillo-Tandazo W; St Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, 3065, Australia., Chalk AM; St Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, 3065, Australia., Pilcher C; St Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.; School of Science, STEM College, RMIT University, Melbourne, Victoria, 3083, Australia., Holien JK; St Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.; School of Science, STEM College, RMIT University, Melbourne, Victoria, 3083, Australia., Heierhorst J; St Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia.; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, 3065, Australia., Tan TY; Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Victoria, 3052, Australia.; Department of Paediatrics, University of Melbourne, Melbourne, Victoria, 3052, Australia., Koren A; Department of Molecular and Cellular Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, 14263, USA., Smeets MF; St Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia., Walkley CR; Centre for Innate Immunity and Infection Diseases, Hudson Institute of Medical Research, Clayton, Victoria, 3168, Australia. carl.walkley@hudson.org.au.; St Vincent's Institute of Medical Research, Fitzroy, Victoria, 3065, Australia. carl.walkley@hudson.org.au.; Department of Medicine, St Vincent's Hospital, University of Melbourne, Fitzroy, Victoria, 3065, Australia. carl.walkley@hudson.org.au.; Department of Molecular and Translational Sciences, Monash University, Clayton, Victoria, 3168, Australia. carl.walkley@hudson.org.au.; Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, 3052, Australia. carl.walkley@hudson.org.au. |
| Source: | EMBO reports [EMBO Rep] 2026 Apr; Vol. 27 (7), pp. 1759-1788. Date of Electronic Publication: 2026 Mar 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 100963049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-3178 (Electronic) Linking ISSN: 1469221X NLM ISO Abbreviation: EMBO Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1469-3178 |
|---|---|
| DOI: | 10.1038/s44319-026-00727-2 |
